In this session, our speakers investigated how the identification of RNAs modified in different conditions can ultimately determine how the ADPr-cap functions in human cells as well as exploring the insufficient development of antiviral strategies in relation to several negative-strand RNA viruses.

Speakers:

• Karla Feijs-Žaja, RWTH Aachen University
• Harry Williams, Bernhard Nocht Institute for Tropical Medicine

This webinar was chaired by Dr Michael Tellier, University of Leicester.